These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 14560766)

  • 41. Artificial Intelligence in Pharmacoepidemiology: A Systematic Review. Part 1-Overview of Knowledge Discovery Techniques in Artificial Intelligence.
    Sessa M; Khan AR; Liang D; Andersen M; Kulahci M
    Front Pharmacol; 2020; 11():1028. PubMed ID: 32765261
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Using Artificial Intelligence Resources in Dialysis and Kidney Transplant Patients: A Literature Review.
    Burlacu A; Iftene A; Jugrin D; Popa IV; Lupu PM; Vlad C; Covic A
    Biomed Res Int; 2020; 2020():9867872. PubMed ID: 32596403
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of Artificial Intelligence in Kidney Disease.
    Yuan Q; Zhang H; Deng T; Tang S; Yuan X; Tang W; Xie Y; Ge H; Wang X; Zhou Q; Xiao X
    Int J Med Sci; 2020; 17(7):970-984. PubMed ID: 32308551
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Individualized drug dosing using RBF-Galerkin method: Case of anemia management in chronic kidney disease.
    Mirinejad H; Gaweda AE; Brier ME; Zurada JM; Inanc T
    Comput Methods Programs Biomed; 2017 Sep; 148():45-53. PubMed ID: 28774438
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Performance of a Predictive Model for Long-Term Hemoglobin Response to Darbepoetin and Iron Administration in a Large Cohort of Hemodialysis Patients.
    Barbieri C; Bolzoni E; Mari F; Cattinelli I; Bellocchio F; Martin JD; Amato C; Stopper A; Gatti E; Macdougall IC; Stuard S; Canaud B
    PLoS One; 2016; 11(3):e0148938. PubMed ID: 26939055
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Minding impacting events in a model of stochastic variance.
    Duarte Queirós SM; Curado EM; Nobre FD
    PLoS One; 2011 Mar; 6(3):e18149. PubMed ID: 21483864
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Computerized decision support for EPO dosing in hemodialysis patients.
    Miskulin DC; Weiner DE; Tighiouart H; Ladik V; Servilla K; Zager PG; Martin A; Johnson HK; Meyer KB;
    Am J Kidney Dis; 2009 Dec; 54(6):1081-8. PubMed ID: 19781831
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Would artificial neural networks implemented in clinical wards help nephrologists in predicting epoetin responsiveness?
    Gabutti L; Lötscher N; Bianda J; Marone C; Mombelli G; Burnier M
    BMC Nephrol; 2006 Sep; 7():13. PubMed ID: 16981983
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Profiled support vector machines for antisense oligonucleotide efficacy prediction.
    Camps-Valls G; Chalk AM; Serrano-López AJ; Martín-Guerrero JD; Sonnhammer EL
    BMC Bioinformatics; 2004 Sep; 5():135. PubMed ID: 15383156
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
    Li H; Wang SX
    Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of route of EPO administration on hemodialysis arteriovenous vascular access failure: a randomized controlled trial.
    Lee YK; Koo JR; Kim JK; Park II; Joo MH; Yoon JW; Noh JW; Vaziri ND
    Am J Kidney Dis; 2009 May; 53(5):815-22. PubMed ID: 19324483
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of high-flux hemodialysis on renal anemia.
    Ayli D; Ayli M; Azak A; Yüksel C; Kosmaz GP; Atilgan G; Dede F; Abayli E; Camlibel M
    J Nephrol; 2004; 17(5):701-6. PubMed ID: 15593038
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Erythropoietin dose requirements when converting from subcutaneous to intravenous administration among patients on hemodialysis.
    Moist LM; Muirhead N; Wazny LD; Gallo KL; Heidenheim AP; House AA
    Ann Pharmacother; 2006 Feb; 40(2):198-203. PubMed ID: 16449549
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dosage individualization of erythropoietin using a profile-dependent support vector regression.
    Martín-Guerrero JD; Camps-Valls G; Soria-Olivas E; Serrano-López AJ; Pérez-Ruixo JJ; Jiménez-Torres NV
    IEEE Trans Biomed Eng; 2003 Oct; 50(10):1136-42. PubMed ID: 14560766
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.